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Abstract
Male steady partners of female sex workers (FSW) living with HIV represent a key population for 
treatment as prevention and/or pre-exposure prophylaxis (PrEP) interventions. This study uses data 
collected from male steady partners who were referred by FSW living with HIV participating in a 
multi-level HIV prevention and care intervention in Santo Domingo, Dominican Republic. We 
conducted a socio-behavioral survey and HIV-testing with all men (n=64) and 16 in-depth 
interviews with a sub-sample to obtain more depth. Thirty-five of the 64 participants were living 
with HIV; 27 were previously diagnosed and 8 were diagnosed during our study. As a result, 45% 
of men were members of a sero-discordant sexual partnerships. Of men with no previous HIV 
diagnosis (n=37), 15 had never been tested for HIV and 9 had not been tested in the past two 
years. Ninety-three percent of men previously diagnosed with HIV reported receiving HIV care in 
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the past 6 months and 78% were taking anti-retrovirals. Low HIV testing was partly due to men 
not feeling at-risk for HIV, despite having an HIV-infected partner. Additionally, a lack of tailored 
care inhibited engagement in ARV treatment for those infected. HIV testing was low, highlighting 
a need for test-and-treat strategies. Men not living with HIV would benefit from regular testing 
and would be good candidates for pre-exposure prophylaxis. While almost all men who had been 
diagnosed with HIV were engaged in care and adherent to ART, future research should assess 
whether they are achieving optimal HIV outcomes for their health and prevention of ongoing 
transmission.
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Introduction
Recent evidence has emphasized the opportunity to use anti-retroviral therapy (ART) for 
both primary and secondary prevention of HIV transmission of HIV (CDC, 2011, 2014). 
People living with HIV who correctly take ART and are virally suppressed have been shown 
to be significantly less infectious than those who are not taking ART (Cohen et al., 2011). In 
response, identifying and linking individuals living with HIV to care and ARV treatment 
immediately, referred to as the “test and treat” and “treatment as prevention” paradigms, 
have emerged globally as a key strategies to prevent ongoing sexual transmission of HIV 
(Cohen et al., 2011; Cohen et al., 2013). Additionally, PrEP (i.e. HIV-negative persons 
taking ART as prophylaxis) has been recommended as an additional tool for HIV prevention 
for people who have behaviors that expose them to HIV (CDC, 2014; Jain, Krakower, & 
Mayer, 2015).
Men who are the steady partners of female sex workers (FSW) living with HIV represent a 
key population to target for ART-based prevention strategies, and yet, to our knowledge, 
there is no published research about this population’s HIV prevalence or experiences with 
HIV testing, care or treatment. Female sex workers and their male partners are key 
populations disproportionately affected by HIV in the Dominican Republic – where we 
conducted this study – and elsewhere (CONAVIHSIDA, 2014; Halperin, de Moya, Perez-
Then, Pappas, & Garcia Calleja, 2009). Though there is no systematic HIV surveillance for 
male steady partners, FSW have a 13.5 times greater odds to be HIV-infected than non-FSW 
women, globally (Baral et al., 2012). The male steady partners of FSW have been shown to 
infrequently use condoms with their FSW partners (Murray et al., 2007; Syvertsen et al., 
2013). In turn, ART-based prevention strategies may be the most effective way to stem HIV 
transmission among this population. Yet, there is some evidence that male steady partners 
may be reluctant to receive HIV testing or engage in medical care (Fleming, Barrington, 
Perez, Donastorg, & Kerrigan, 2015). For the specific population of male steady partners of 
FSW living with HIV, it is unclear how this population might be reached, how many are 
living with HIV, and if and how they have engaged with HIV testing, care, and treatment.
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With the aim of informing ART-based prevention strategies, we conducted a mixed-methods 
study in Santo Domingo, Dominican Republic (DR) to (a) examine the feasibility of 
recruiting male steady partners of FSW living with HIV for HIV testing and socio-
behavioral research, and (b) describe this population’s HIV prevalence and testing, care, and 
treatment experiences.
Methods
In this paper, we present findings from a socio-behavioral quantitative survey, HIV testing, 
and in-depth interviews conducted with men in the DR who were the steady partners (e.g. 
boyfriend, husband) of a FSW living with HIV.
Sample and recruitment
This study with male partners was embedded within Abriendo Puertas (Opening Doors), 
(Donastorg, Barrington, Perez, & Kerrigan, 2014), a longitudinal intervention research 
project conducted among FSW living with HIV in Santo Domingo. Our team previously 
conducted a study with steady male partners of FSW in the DR in which we asked their 
preferences and suggestions for recruiting other men into research studies (Fleming et al., 
2015). We drew upon the recommendations – making men feel comfortable in the research 
setting and using partner and peer referrals – to recruit men for this study (Fleming et al., 
2015).
Men were referred by FSW participants (n=268) in the Abriendo Puertas intervention. FSW 
were defined as women who reported having exchanged sex for money in the last month and 
‘male steady partners’ were defined as someone who was considered to be an ongoing or 
steady partner who had sex with a participating FSW at least 4 times in the last 3 months. 
FSW enrolled in Abriendo Puertas were asked – but not required – to refer their male steady 
partners for HIV testing and a socio-behavioral survey. All male steady partners and FSW 
were at least 18 years old at the time of consent and spoke Spanish. The HIV status and 
involvement in sex work of the referring FSW participant were not disclosed by our study 
team to the male partners, including when a male partner tested positive for HIV. Counselors 
were trained especially for such situations to help male partners process their diagnosis 
without disclosing the HIV-status (including deductive disclosure) of the partner that 
referred him.
Data collection procedures
We conducted an interviewer-administered standardized socio-behavioral survey and HIV 
testing with each man. A purposive sample based of sixteen men based on their HIV status 
were additionally invited to participate in a qualitative in-depth interview about their 
experiences with HIV testing and, if applicable, HIV care. All data collection occurred in 
Spanish in private research offices by trained Dominican field staff.
HIV testing for men included two rapid tests (Determine and Retrocheck), followed by an 
enzyme-linked immunosorbent assay (ELISA) test in the case of discordance. All male 
partners who tested positive for HIV were linked to care and treatment. HIV-negative men 
received individual-level HIV risk reduction counseling.
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Survey data were analyzed using SAS version 9.4. We conducted univariate analysis to 
describe the population and to establish a baseline level of biological and behavioral study 
outcomes. For the in-depth interviews, we transcribed the audio-recorded interviews and 
used thematic coding procedures (in Atlas.ti version 7) to describe and examine men’s 
experiences with HIV testing, care, and treatment and relationship with their partner 
(Saldaña, 2009). Subsequently, we reviewed outputs from these coding exercises to prepare 
matrices around each theme for comparative analysis of patterns across participants. 
Qualitative data analysis occurred after quantitative analyses and we used the qualitative 
data to explore in greater depth findings from the quantitative data.
Ethical approval
All study protocols and consent procedures were approved by the Institutional Review 
Boards of the Johns Hopkins Bloomberg School of Public Health, the University of North 
Carolina, and the Instituto Dominicano de Dermatología y Cirugía de la Piel “Dr. Huberto 
Bogaert Diaz.”
Results
A total of 250 FSW living with HIV participated in Abriendo Puertas and were asked to 
refer their steady male sexual partners. Approximately a quarter of the cohort made such a 
referral over the 10-month initial study period resulting in sixty-four male steady partners 
recruited into the study. Socio-demographic characteristics of these men are presented in 
Table 1. Most men (64.5%) said that the woman who referred them to the study was a co-
habiting partner and 87.5% reported their partner was engaged in sex work. The men ranged 
in age between 20 and 67 (median: 39) and over two thirds (70.9%) had primary education 
or less. Most men (82.8%) were employed and their median monthly income was 9500 
Dominican pesos or about 215 US Dollars (range: 1800–160,000 pesos). Five men (7.9%) 
self-reported having a sexually transmitted infection other than HIV in the past 6 months, 22 
men (34.4%) had more than one sex partner in the previous 30 days, and 22 men (34.4%) 
did not use a condom at last sex with the FSW partner living with HIV that referred them. In 
terms of substance use, 39.7% drank alcohol once a week or more in the past 30 days, 42.7% 
had ever used illicit drugs, and 9.5% had used illicit drugs in the past 6 months. Thirteen 
percent reported having ever sold drugs.
Thirty-five (54.7%) of the 64 men were infected with HIV; 27 (42.2%) had previously 
known their positive status and 8 (12.5%) were newly diagnosed during our study. Of the 37 
men with no previous HIV diagnosis, 15 (40.5%) had never been tested for HIV and 9 
(24.3%) had not been tested in the previous two years.
HIV testing experiences
We asked the men about their experiences with HIV testing (Table 2). Of those men who had 
previously tested for HIV prior to our study (n=49), 34 (69.4%) were tested most recently in 
a hospital/clinic; 9 (18.4%) in a mobile testing unit and 6 (12.2%) by an NGO. Of the men 
previously tested, 30.6% said they tested because of a doctor’s recommendation, 26.5% 
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because they suspected a sexual partner was living with HIV, and 18.4% were tested because 
they felt sick. Just over half of men who were tested reported receiving counseling before 
and after HIV testing.
In the qualitative interviews, men described reasons for non-testing. Many men discussed 
their anxiety related to testing, in particular due to fear of a positive result. For example, one 
52-year-old man who had never been tested prior to this study said, “Because I had never 
done it, and when you haven’t done something before you always think the worst.”
Other men did not feel that they were at risk for HIV and never felt a need to get tested. As 
an example, one man who received a positive HIV diagnosis as part of this study had never 
previously been tested. He described the partner who referred him as his lover and he had 
two children with her; however, he also had a wife with whom he lived. This man knew that 
the partner who referred him was a sex worker but he was unaware that she was living with 
HIV, though he believed she had been tested (“She’s gotten tested twice and has been 
negative…[I know] because she has told my mom.”). He said his condom use with his lover 
(i.e. the partner who was a FSW living with HIV) was inconsistent, especially when 
drinking. Despite having unprotected sex with his lover and with other partners, he said that 
he did not feel like he could be infected with HIV and so he had never been tested before. 
He said, “Here was the first time [I was tested]…I had never been tested for HIV…I never 
really thought about it.” He expressed shock at his positive diagnosis, saying “I wasn’t 
expecting this.” While many men with similar stories similar ended up testing negative for 
HIV, this man’s story highlights how lack of awareness of risk delayed HIV testing.
HIV Care Experiences
Twenty-seven of the 64 men referred had previously been diagnosed with HIV and were 
asked about their HIV care experiences (Table 3). Of those 27 men, 11 (40.7%) were 
diagnosed within the previous two years, 9 (33.3%) had received their diagnosis over two 
years ago, and 7 could not remember. All but one man with a previous HIV diagnosis had 
disclosed their HIV status to someone other than a medical provider and fifteen (55.6%) had 
disclosed to the woman who referred them to the study.
Twenty-five (92.6%) had received HIV care in the past 6 months and had previously had a 
CD4 count taken. Most men were satisfied with their experiences with HIV care. All men 
who had received HIV care reported that they felt respected by clinic staff, and 22 (88.0%) 
reported that overall the HIV services are generally ‘excellent/good.’ Twenty-one (77.8%) 
men with a previous diagnosis were taking antiretroviral (ARV) treatment. Only three 
(14.3%) had started ARVs within the past year, 10 (47.6%) began it 1 to 5 years ago, and 8 
(35.1%) started ARVs over 5 years. Of those currently taking ARVs, 90.5% said they were 
following their prescribed doses ‘perfectly.’
While men in the qualitative interviews echoed the overall positive experiences in HIV care, 
several highlighted that wait times in clinics pose a challenge to their successful utilization 
of HIV care and treatment. As an example, one man who was referred to the study by his 
wife of 18 years had been diagnosed with HIV ten years ago and he knew that his wife was 
living with HIV. He had mostly had good experiences with doctors and nurses during his 
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HIV care visits, but he faced challenges when trying to pick up his ARV treatment each 
month. He said,
“Well, actually I find it to be really difficult [to get my medication] because I think 
that if I’m just coming to get my medication, I shouldn’t have to wait a long time…
I don’t think they should let someone who isn’t there to see a doctor but rather is 
just looking for his medications to wait the for 4 or 5 hours, I don’t think that’s 
right…We’re just poor workers and I can’t be paralyzed there.”
This quote highlights the impact of long wait times to pick up medication on his ability to 
work and make money. Other men mentioned long wait times as the biggest barrier to 
receiving HIV care and treatment.
Discussion
We successfully recruited 64 male steady partners of FSW living with HIV – a population 
that has never previously been studied – by using partner referrals. We found that over half 
of these men were living with HIV and just over half those men had disclosed their status to 
their FSW partner. Additionally, HIV testing was fairly low among men who did not have a 
previous HIV diagnosis; eight men were newly diagnosed as part of our study. Most men 
who were living with HIV were engaged in HIV care and satisfied with the quality, but 
noted that wait times posed a barrier to adherence to care and their ability to work.
Regular HIV testing was low among steady male partners of FSW living with HIV, which is 
an important gap to address given the potential for transmission within these sexual 
networks. Future efforts need to specifically target steady male partners for ART-based 
prevention efforts, especially regular HIV testing and PrEP. Partner referral by FSW living 
with HIV who are engaged in care is one option to reach these men, when women feel 
comfortable with this (Fleming et al., 2015). Ultimately, outreach efforts needs to make HIV 
testing more normative among male populations and specifically men who are partners of 
FSW living with HIV. Such efforts should directly address fear associated with a positive 
diagnosis since many men felt anxiety about being diagnosed.
Beyond HIV testing, male steady partners who test positive for HIV are a key population for 
treatment as prevention interventions to ensure linkage to care and treatment. Those who test 
negative and continue to be in steady relationships with an infected FSW partner are prime 
candidates for pre-exposure prophylaxis (PrEP) interventions (CDC, 2014; Jain et al., 2015). 
Almost half of the male steady partners in our study (45.3%) were members of a sero-
discordant sexual partnerships, highlighting the potential promise for PrEP with this 
population. Future research should explore the feasibility of PrEP for this population.
The most salient barrier to successful ARV adherence was long wait times. Clinics may need 
to reorient their provision of care to acknowledge men’s (and women’s) need to work 
(Dovel, Yeatman, Watkins, & Poulin, 2015; Fleming & Dworkin, 2016). Work is often 
central to men’s masculine identity and thus men may prioritize work obligations more so 
than their health (Axelrod, 2001). Research by Siu and colleagues in Uganda emphasize how 
ARV treatment can inhibit men’s work and diminish their self-perceived masculinity. 
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Medication pick-up may need to be available on evenings and weekends to allow for people 
to earn money during regular working hours.
Just over half of men in our sample who had previously been diagnosed with HIV had 
disclosed their HIV status to the FSW partner who referred them to the study. This suggests 
that there are significant barriers to HIV disclosure among this population that merits more 
exploration to determine whether the barriers to disclosure for this population are similar to 
those found in other populations (e.g. HIV stigma and discrimination) (Przybyla et al., 
2013). There is some evidence to suggest that partners can help each other with HIV care 
and treatment (Nachega et al., 2006; Skhosana et al. 2006; Stirratt et al., 2006; Klitzman et 
al. 2004), but unfortunately, to our knowledge, these dynamics have never been looked at 
specifically among FSW living with HIV and their male partners. A recent systematic 
review of rigorously evaluated interventions for partner disclosure found none targeting 
heterosexual men or female sex workers and their male partners, highlighting a gap in the 
current literature (Conserve, Groves, Maman, 2015). More research in this area is needed to 
determine whether overcoming these barriers to disclosure could be important for improving 
HIV treatment outcomes for this population.
While our study provides important insights into the HIV testing, care and treatment 
experiences of a key population for HIV transmission in the Dominican Republic, several 
limitations must be acknowledged. We did not assess biologic HIV outcomes, such as viral 
load and CD4 counts, which would provide important indicators of care and treatment 
effectiveness. Additionally, our quantitative sample is small and only includes men whose 
FSW partners were willing to make referrals. We would expect that FSW who were willing 
to refer were more like to have previously disclosed their HIV status, though, of note, we did 
have men in our sample whose partners had not disclosed. Our small and non-random 
sample may not be representative of the population as a whole. Recruitment of male partners 
of FSW is a challenge that can be a barrier to research with this population (Fleming et al., 
2015). To recruit greater numbers of men into such research, we learned in this study and 
previous research that it is critical to guarantee confidentiality for both FSW and their 
partners (Fleming et al., 2015). In order to increase referrals from FSW of their male 
partners, it is important to assess the nature of the relationship and tailor the process based 
on whether the woman wants to accompany her partner, engage with someone else to recruit 
her partner (such as a peer navigator or family member), or simply provide information to 
her partner. It could be fruitful for those FSW who have referred their partners to share their 
experiences with others to emphasize that the research team did not disclose information 
about HIV status or status as a FSW. Beyond FSW referrals, which may not be feasible or 
desired by some women, efforts that promote testing within social networks of male partners 
through opinion leaders and offer testing in discrete community locations in evening hours 
with support for linkage to care could be successful. Despite the sample size limitations of 
this work, through our mixed methods approach we were able to provide a more nuanced 
account of the HIV testing, care and treatment experiences of these men.
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Male steady partners of FSW who are living with HIV represent an important but 
understudied population for ARV-based prevention efforts. Better understanding of this 
population – and their relationships with FSW living with HIV – will allow for the 
development of interventions that stem the transmission of HIV between these men and their 
sexual networks.
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Table 1
Demographic characteristics of male steady partners of FSW living with HIV participating in the Abriendo 




 None/Primary 70.9% 44
 Secondary/University 20.9% 18
Cohabits with Referring FSW Partner 64.5% 40
Employed 82.8% 53
Monthly income RDP 9500* (1800–160000)
Aware that referring FSW partner is a FSW 87.5% 56
Self-reported STI in past 6 months 7.9% 5
More than 1 sex partner, past 30 days 34.4% 22
Unprotected last sex with referring FSW partner 34.4% 22
Alcohol use once a week or more in past 30 days 39.7% 25
Ever used illicit drugs 42.9% 27
Any drug use past 6 months 9.5% 6
Ever involved in selling drugs 12.9% 8
HIV Status
 HIV-negative 45.3% 29
 HIV-positive (newly diagnosed in our study) 12.5% 8
 HIV-positive (previously diagnosed) 42.2% 27
HIV testing among men without previous diagnosis (n=37)
 Never had previous HIV test 40.5% 15
 Had previous HIV test, but not in past 2 years 24.3% 9
 Tested for HIV within the past 2 years 35.1% 13
*
Approximately USD 215
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Table 2
HIV testing experiences of male steady partners of FSW living with HIV (n=64)
Percent Count
Ever tested for HIV (prior to our study) 76.6% 49
Location of last HIV test, prior to our study
 Hospital/Clinic 69.4% 34
 Mobile testing unit 18.4% 9
 NGO 12.2% 6
Reasons for last HIV test
 Doctor recommendation 30.6% 15
 Felt sick 18.4% 9
 Felt at risk 12.2% 6
 Was with someone suspected of being HIV+ 26.5% 13
 Required for work 4.1% 2
 Other 8.2% 4
Received counseling before last HIV test 52.1% 25
Received counseling after last HIV test 56.3% 27
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Table 3
HIV care and ARV experiences of male steady partners with a previous HIV diagnosis (n=27)
Percent Count
Date of diagnosis
 Diagnosed in previous 2 years 40.7% 11
 Diagnosed over 2 years ago 33.3% 9
 Unknown 25.9% 7
Previously disclosed HIV status to
 Non-medical worker 96.3% 26
 Partner who referred him to study 55.6% 15
Received HIV care in last 6-months 92.6% 25
Has previously had CD4 count taken 92.6% 25
Has previously had viral load taken 88.9% 24
Always feels treated with respect by health clinic staff (n=25) 100.00% 25
The HIV services received are generally (n=25)
 Excellent/Good 88.0% 22
 Adequate 8.0% 2
 Weak 4.0% 1
Currently on ARV treatment 77.8% 21
First time took ARVs (n=21)
 Within past year 14.3% 3
 1–5 years ago 47.6% 10
 More than 5 years ago 38.1% 8
Perfect ARV adherence (n=21) 90.5% 19
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